Solstein Capital LLC Takes Position in Doximity, Inc. $DOCS

Solstein Capital LLC acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 12,090 shares of the company’s stock, valued at approximately $742,000.

A number of other hedge funds also recently made changes to their positions in DOCS. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Doximity by 130.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock valued at $114,133,000 after purchasing an additional 1,113,076 shares during the period. Vanguard Group Inc. increased its stake in shares of Doximity by 8.8% in the first quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock worth $707,646,000 after buying an additional 990,923 shares during the last quarter. Invesco Ltd. increased its stake in shares of Doximity by 54.8% in the first quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock worth $114,280,000 after buying an additional 696,923 shares during the last quarter. William Blair Investment Management LLC increased its stake in shares of Doximity by 13.8% in the second quarter. William Blair Investment Management LLC now owns 5,219,394 shares of the company’s stock worth $320,158,000 after buying an additional 634,927 shares during the last quarter. Finally, Nuveen LLC bought a new stake in shares of Doximity in the first quarter worth $34,056,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Insider Activity

In other news, Director Regina M. Benjamin sold 5,000 shares of the business’s stock in a transaction on Friday, October 10th. The shares were sold at an average price of $70.84, for a total transaction of $354,200.00. Following the completion of the transaction, the director owned 19,839 shares of the company’s stock, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the transaction, the director directly owned 3,221 shares of the company’s stock, valued at approximately $241,575. This trade represents a 86.13% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 37,000 shares of company stock valued at $2,635,880. 31.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts recently issued reports on DOCS shares. Canaccord Genuity Group lifted their price target on shares of Doximity from $59.00 to $67.00 and gave the stock a “hold” rating in a research note on Thursday, September 18th. Zacks Research lowered shares of Doximity from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Piper Sandler lifted their price target on shares of Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Wells Fargo & Company lifted their price target on shares of Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a research note on Monday, August 4th. Finally, Raymond James Financial set a $75.00 price target on shares of Doximity in a research note on Wednesday, September 10th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $69.37.

Doximity Price Performance

DOCS stock opened at $66.93 on Monday. Doximity, Inc. has a 1-year low of $40.87 and a 1-year high of $85.21. The firm has a fifty day moving average price of $69.60 and a two-hundred day moving average price of $61.85. The firm has a market cap of $12.54 billion, a price-to-earnings ratio of 66.93, a PEG ratio of 4.10 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter last year, the business earned $0.28 earnings per share. The company’s revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts expect that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.